Garratt PJ - Search Results

1

Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.

Tsotinis A, Vlachou M, Papahatjis DP, Calogeropoulou T, Nikas SP, Garratt PJ, Piccio V, Vonhoff S, Davidson K, Teh MT, Sugden D. Tsotinis A, et al. Among authors: garratt pj. J Med Chem. 2006 Jun 15;49(12):3509-19. doi: 10.1021/jm0512544. J Med Chem. 2006. PMID: 16759094

2

7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.

Faust R, Garratt PJ, Trujillo Pérez MA, Piccio VJ, Madsen C, Stenstrøm A, Frølund B, Davidson K, Teh MT, Sugden D. Faust R, et al. Among authors: garratt pj. Bioorg Med Chem. 2007 Jul 1;15(13):4543-51. doi: 10.1016/j.bmc.2007.04.013. Epub 2007 Apr 10. Bioorg Med Chem. 2007. PMID: 17459711

3

Synthesis of compounds as melatonin agonists and antagonists.

Garratt PJ, Tsotinis A. Garratt PJ, et al. Mini Rev Med Chem. 2007 Oct;7(10):1075-88. doi: 10.2174/138955707782110132. Mini Rev Med Chem. 2007. PMID: 17979811 Review.

4

Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.

Garratt PJ, Jones R, Tocher DA, Sugden D. Garratt PJ, et al. J Med Chem. 1995 Mar 31;38(7):1132-9. doi: 10.1021/jm00007a010. J Med Chem. 1995. PMID: 7707316

5

Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.

Garratt PJ, Travard S, Vonhoff S, Tsotinis A, Sugden D. Garratt PJ, et al. J Med Chem. 1996 Apr 26;39(9):1797-805. doi: 10.1021/jm9508189. J Med Chem. 1996. PMID: 8627603

6

Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.

Davies DJ, Garratt PJ, Tocher DA, Vonhoff S, Davies J, Teh MT, Sugden D. Davies DJ, et al. Among authors: garratt pj. J Med Chem. 1998 Feb 12;41(4):451-67. doi: 10.1021/jm970246n. J Med Chem. 1998. PMID: 9484496

7

Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.

Faust R, Garratt PJ, Jones R, Yeh LK, Tsotinis A, Panoussopoulou M, Calogeropoulou T, Teh MT, Sugden D. Faust R, et al. Among authors: garratt pj. J Med Chem. 2000 Mar 23;43(6):1050-61. doi: 10.1021/jm980684+. J Med Chem. 2000. PMID: 10737738

8

Binding affinity and biological activity of oxygen and sulfur isosteres at melatonin receptors as a function of their hydrogen bonding capability.

Davies DJ, Faust R, Garratt PJ, Marivingt-Mounir C, Kathryn Davidson, Teh MT, Sugden D. Davies DJ, et al. Among authors: garratt pj. Bioorg Chem. 2004 Feb;32(1):1-12. doi: 10.1016/j.bioorg.2003.09.004. Bioorg Chem. 2004. PMID: 14700558

9

Benzocyclobutane, benzocycloheptane and heptene derivatives as melatonin agonists and antagonists.

Tsotinis A, Afroudakis PA, Garratt PJ, Bocianowska-Zbrog A, Sugden D. Tsotinis A, et al. Among authors: garratt pj. ChemMedChem. 2014 Oct;9(10):2238-43. doi: 10.1002/cmdc.201402122. Epub 2014 Jul 8. ChemMedChem. 2014. PMID: 25044938

10

Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists.

Tsotinis A, Kompogennitaki R, Papanastasiou I, Garratt PJ, Bocianowska A, Sugden D. Tsotinis A, et al. Among authors: garratt pj. Medchemcomm. 2019 Feb 11;10(3):460-464. doi: 10.1039/c8md00604k. eCollection 2019 Mar 1. Medchemcomm. 2019. PMID: 31191854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters